The DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessAbstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A., & Wilson, W. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis803 · Cited by 2,266
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Self-citationTande, A. J., & Patel, R. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-13 · Cited by 1,885
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Berbari, E. F., Kanj, S. S., Kowalski, T. J., Darouiche, R. O., Widmer, A. F., Schmitt, S. K., Hendershot, E. F., Holtom, P. D., Huddleston, P. M., Petermann, G. W., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ482 · Cited by 1,142
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A., & Wilson, W. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis966 · Cited by 924
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 878
Evaluation and Management of Penicillin Allergy: A Review
Shenoy, E. S., Macy, E., Rowe, T., & Blumenthal, K. G. (2019) · JAMA · doi:10.1001/jama.2018.19283 · Cited by 830
Norris, A. H., Shrestha, N. K., Allison, G. M., Keller, S. C., Bhavan, K. P., Zurlo, J. J., Hersh, A. L., Gorski, L. A., Bosso, J. A., Rathore, M. H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy745 · Cited by 372
Saavedra-Lozano, J., Falup-Pecurariu, O., Faust, S. N., Girschick, H., Hartwig, N., Kaplan, S., Lorrot, M., Mantadakis, E., Peltola, H., Rojo, P., et al. (2017) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001635 · Cited by 283
Chapman, A. L. N., Dixon, S., Andrews, D., Lillie, P. J., Bazaz, R., & Patchett, J. D. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp343 · Cited by 261
Keren, R., Shah, S. S., Srivastava, R., Rangel, S. J., Bendel-Stenzel, M. R., Harik, N., Hartley, J., Lopez, M. A., Seguias, L., Tieder, J. S., et al. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2014.2822 · Cited by 233
Treating Osteomyelitis: Antibiotics and Surgery
Rao, N., Ziran, B. H., & Lipsky, B. A. (2011) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3182001f0f · Cited by 224
Dunne, M. W., Puttagunta, S., Giordano, P., Krievins, D. K., Zelasky, M. T., & Baldassarre, J. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ982 · Cited by 224
Chapman, A. L. N., Seaton, R. A., Cooper, M. A., Hedderwick, S., Goodall, V., Reed, C., Sanderson, F., Nathwani, D., & on behalf of the BSAC/BIA OPAT Project Good Practice Recommendations Working Group (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks003 · Cited by 197
Intracranial Microbial Aneurysm (Infectious Aneurysm): Current Options for Diagnosis and Management
Kannoth, S., & Thomas, S. V. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9208-x · Cited by 195
Norris, A. H., Shrestha, N. K. M., Allison, G. M., Keller, S. C., Bhavan, K., Zurlo, J. J., Hersh, A. L., Gorski, L. A., Bosso, J. A., Rathore, M. H., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy867 · Cited by 189
Blumenthal, K. G., Shenoy, E. S., Varughese, C. A., Hurwitz, S., Hooper, D. C., & Banerji, A. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.05.011 · Cited by 185
Matthews, P. C., Conlon, C. P., Berendt, A. R., Kayley, J., Jefferies, L., Atkins, B. L., & Byren, I. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm210 · Cited by 180
Acute Pyelonephritis in Adults
Johnson, J. R., & Russo, T. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1702758 · Cited by 179
Gould, F. K., Brindle, R. J., Chadwick, P. R., Fraise, A. P., Hill, S., Nathwani, D., Ridgway, G. L., Spry, M. J., Warren, R. E., & on behalf of the MRSA Working Party of the British Society for Antimicrobial Chemotherapy (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp065 · Cited by 173
Outpatient parenteral antimicrobial therapy today
Paladino, J. A., & Poretz, D. (2010) · Clinical Infectious Diseases · doi:10.1086/653520 · Cited by 167
Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship
Blumenthal, K. G., Wickner, P. G., Hurwitz, S., Pricco, N., Nee, A. E., Laskowski, K. R., Shenoy, E. S., & Walensky, R. P. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.005 · Cited by 157
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections
Goebel, M. C., Trautner, B. W., & Grigoryan, L. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00003-20 · Cited by 157
Baddour, L. M., Weimer, M. B., Wurcel, A. G., McElhinney, D. B., Marks, L. R., Fanucchi, L. C., Garrigos, Z. E., Pettersson, G., & DeSimone, D. C. (2022) · Circulation · doi:10.1161/cir.0000000000001090 · Cited by 152
Barr, D. A., Semple, L., & Seaton, R. A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.016 · Cited by 150
Suzuki, J., Johnson, J., Montgomery, M. W., Hayden, M. C., & Price, C. N. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy194 · Cited by 146
The infective endocarditis team: recommendations from an international working group
Chambers, J. B., Sandoe, J. A. T., Ray, S. G., Prendergast, B., Taggart, D. P., Westaby, S., Arden, C., Grothier, L., Wilson, J., Campbell, B., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304354 · Cited by 140
Allison, G. M., Muldoon, E. G., Kent, D. M., Paulus, J. K., Ruthazer, R., Ren, A., & Snydman, D. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit920 · Cited by 128
Durojaiye, O. C., Bell‐Gorrod, H., Andrews, D., Ntziora, F., & Cartwright, K. E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.016 · Cited by 125
Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy
Keller, S. C., Williams, D., Gavgani, M., Hirsch, D., Adamovich, J., Hohl, D., Gürses, A. P., & Cosgrove, S. E. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix733 · Cited by 124
Self-citationYoung, J. D., Abdel-Massih, R. C., Herchline, T., McCurdy, L., Moyer, K. J., Scott, J. D., Wood, B. R., & Siddiqui, J. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy907 · Cited by 120
Li, J., Echevarria, K. L., Hughes, D. W., Cadena, J. A., Bowling, J. E., & Lewis, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02800-14 · Cited by 117
Maréchal, M. L., Tebano, G., Monnier, A. A., Adriaenssens, N., Gyssens, I. C., Huttner, B. D., Milanič, R., Schouten, J. A., Benić, M. S., Versporten, A., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky117 · Cited by 116
The history and evolution of outpatient parenteral antibiotic therapy (OPAT)
Williams, D. N., Baker, C. A., Kind, A., & Sannes, M. R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.001 · Cited by 113
Self-citationOutpatient parenteral antibiotic therapy: Principles and practice
Seaton, R. A., & Barr, D. A. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.03.014 · Cited by 112
Siddiqui, J., Herchline, T., Kahlon, S. S., Moyer, K. J., Scott, J. D., Wood, B. R., & Young, J. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw773 · Cited by 109
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists
Gilchrist, M. J., & Seaton, R. A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku517 · Cited by 109
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Hamed, K. A., González-Ruiz, A., & Seaton, A. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s99046 · Cited by 102
The value of an “Endocarditis Team”
Davierwala, P. M., Cuartas, M. M., Misfeld, M., & Borger, M. A. (2019) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2019.09.03 · Cited by 99
MacKenzie, M., Rae, N., & Nathwani, D. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.006 · Cited by 99
Ho, J., Archuleta, S., Sulaiman, Z., & Fisher, D. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq355 · Cited by 99
Management of Prosthetic Joint Infection
Tande, A. J., Urena, E. O. G., Berbari, E. F., & Osmon, D. R. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.01.009 · Cited by 97
Youngster, I., Shenoy, E. S., Hooper, D. C., & Nelson, S. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu301 · Cited by 96
Blumenthal, K. G., Parker, R. A., Shenoy, E. S., & Walensky, R. P. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ394 · Cited by 95
Outpatient Parenteral Antimicrobial Therapy
Laupland, K. B., & Valiquette, L. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/205910 · Cited by 94
Katz, D. E., Lindfield, K. C., Steenbergen, J. N., Benziger, D. P., Blackerby, K. J., Knapp, A. G., & Martone, W. J. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01854.x · Cited by 93
Moran, G. J., Abrahamian, F. M., LoVecchio, F., & Talan, D. A. (2013) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.11.050 · Cited by 89
Bryson‐Cahn, C., Beieler, A. M., Chan, J. D., Harrington, R. D., & Dhanireddy, S. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz028 · Cited by 85
s, J. M. P., Llopis, J., Ramallo, V. J. G., Goenaga, M. Á., Muñóz, P., García-Leoni, M. E., Fariñas, M. C., Pajarón, M., Ambrosioni, J., Luque, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz030 · Cited by 83
Huck, D. M., Ginsberg, J., Gordon, S. M., Nowacki, A. S., Rehm, S. J., & Shrestha, N. K. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt303 · Cited by 81
Self-citationCervera, C., del Río, A., García, L., Sala, M., Almela, M., Moreno, A., Falces, C., Mestres, C. A., Marco, F., Robau, M., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.05.007 · Cited by 80
Coenen, S., Müller, A., Adriaenssens, N., Vankerckhoven, V., Hendrickx, E., & Goossens, H. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp135 · Cited by 78
Heintz, B. H., Halilovic, J., & Christensen, C. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q240 · Cited by 78
Zeller, V., Durand, F., Kitzis, M.-D., Lhotellier, L., Ziza, J.-M., Mamoudy, P., & Desplaces, N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00389-08 · Cited by 76
Chary, A., Tice, A. D., Martinelli, L. P., Liedtke, L. A., Plantenga, M. S., Strausbaugh, L. J., & for the Infectious Diseases Society of America Emerging Infections Network (2006) · Clinical Infectious Diseases · doi:10.1086/508456 · Cited by 75
Self-citationMuldoon, E. G., Snydman, D. R., Penland, E. C., & Allison, G. M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit211 · Cited by 75
Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and Stability
Manning, L. A., Wright, C. M., Ingram, P. R., Whitmore, T., Heath, C. H., Manson, I., Page‐Sharp, M., Salman, S., Dyer, J. R., & Davis, T. M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102023 · Cited by 75
The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy
Hodgson, K. A., Huynh, J., Ibrahim, L. F., Sacks, B., Golshevsky, D., Layley, M., Spagnolo, M., Raymundo, C.-M., & Bryant, P. A. (2016) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-309731 · Cited by 75
Managing infective endocarditis in the elderly: new issues for an old disease
Forestier, E., Fraisse, T., Baudron, C. R., Selton‐Suty, C., & Pagani, L. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s101902 · Cited by 73
Macy, E. M., McCormick, T. A., Adams, J., Crawford, W., Nguyen, M. T., Hoang, L., Eng, V., Davis, A., & McGlynn, E. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8367 · Cited by 72
Continuous Clindamycin Infusion, an Innovative Approach to Treating Bone and Joint Infections
Zeller, V., Dzeing‐Ella, A., Kitzis, M.-D., Ziza, J.-M., Mamoudy, P., & Desplaces, N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01081-09 · Cited by 72
Wieland, B. W., Marcantoni, J. R., Bommarito, K. M., Warren, D. K., & Marschall, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir857 · Cited by 71
Voumard, R. R., Gardiol, C., André, P., Arensdorff, L., Cochet, C., Boillat‐Blanco, N., Decosterd, L. A., Buclin, T., & Vallière, S. D. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky224 · Cited by 71
Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy
Means, L., Bleasdale, S. C., Sikka, M. K., & Gross, A. E. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1799 · Cited by 69
Eckmann, C., Lawson, W., Nathwani, D., Solem, C. T., Stephens, J., Macahilig, C. P., Simoneau, D., Hajek, P., Charbonneau, C., Chambers, R. B., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.04.007 · Cited by 68
Medically-managed Hospital in the Home: 7 year study of mortality and unplanned interruption
Montalto, M., Lui, B., Mullins, A., & Woodmason, K. (2010) · Australian Health Review · doi:10.1071/ah09771 · Cited by 68
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections
Stewart, C. L., Turner, M. S., Frens, J. J., Snider, C. B., & Smith, J. R. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0156-z · Cited by 68
Outpatient Parenteral Antibiotic Therapy for Bone and Joint Infections: An Italian Multicenter Study
Esposito, S., Leone, S., Noviello, S., Ianniello, F., Fiore, M., Russo, M. C., Foti, G., Carpentieri, M. S., Cellesi, C., Zanelli, G., et al. (2007) · Journal of Chemotherapy · doi:10.1179/joc.2007.19.4.417 · Cited by 68
A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective
Yong, C., Fisher, D. A., Sklar, G. E., & Li, S. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.016 · Cited by 66
Amodeo, M. R., Clulow, T., Lainchbury, J. G., Murdoch, D., Gallagher, K., Dyer, A., Metcalf, S. C. L., Pithie, A. D., & Chambers, S. T. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.009 · Cited by 64
Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians
Lane, M., Marschall, J., Beekmann, S. E., Polgreen, P. M., Banerjee, R., Hersh, A. L., & Babcock, H. M. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/676859 · Cited by 64
Patel, S. V., Abrahamson, E., Goldring, S., Green, H. E., Wickens, H. J., & Laundy, M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku401 · Cited by 64
Home Intravenous Antimicrobial Infusion Therapy: A Viable Option in Older Adults
Cox, A. M., Malani, P., Wiseman, S. W., & Kauffman, C. A. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01133.x · Cited by 64
Saillen, L., Arensdorff, L., Moulin, E., Voumard, R. R., Cochet, C., Boillat‐Blanco, N., Gardiol, C., & Vallière, S. D. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2944-5 · Cited by 63
Rehm, S. J., Campion, M., Katz, D. E., Russo, R., & Boucher, H. W. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp051 · Cited by 63
Self-citationMadaline, T. F., Nori, P., Mowrey, W. B., Zukowski, E., Gohil, S. K., Sarwar, U. N., Weston, G. D., Urrely, R., Palombelli, M., Pierino, V. F., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx097 · Cited by 63
Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal Infections
Yi, J., Wood, J. B., Creech, C. B., Williams, D. J., Jimenez‐Truque, N., Yildirim, I. B., Sederdahl, B. K., Daugherty, M., Hussaini, L., Munye, M., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.03.028 · Cited by 62
Self-citationAnemüller, R., Belden, K. A., Brause, B. D., Çıtak, M., del Pozo, J. L., Frommelt, L., Gehrke, T. A., Hewlett, A. L., Higuera, C. A., Hughes, H. C., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.032 · Cited by 62
Kieran, J., O’Reilly, A., Parker, J., Clarke, S., & Bergin, C. J. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0794-5 · Cited by 61
Buehrle, D. J., Shields, R. K., Shah, N. B., Shoff, C. J., & Sheridan, K. M. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx102 · Cited by 60
Outpatient parenteral antimicrobial therapy
Chapman, A. L. N. (2013) · BMJ · doi:10.1136/bmj.f1585 · Cited by 59
Gilchrist, M. J., Franklin, B. D., & Patel, J. P. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn152 · Cited by 59
Bhavan, K., Brown, L. S., & Haley, R. W. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001922 · Cited by 59
Quintens, C., Steffens, E., Jacobs, K., Schuermans, A., Eldere, J. V., Lagrou, K., Munter, P. D., Derdelinckx, I., Peetermans, W. E., & Spriet, I. (2020) · Infection · doi:10.1007/s15010-020-01398-4 · Cited by 59
Wynn, M., Dalovisio, J. R., Tice, A. D., & Jiang, X. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000145300.28736.bb · Cited by 59
Self-citationDaptomycin: rationale and role in the management of skin and soft tissue infections
Seaton, R. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn368 · Cited by 59
Lee, B., Tam, I., Weigel, B., Breeze, J. L., Paulus, J. K., Nelson, J., & Allison, G. M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv130 · Cited by 58
Seaton, R. A., Bell, E., Gourlay, Y., & Semple, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki092 · Cited by 58
Madigan, T., & Banerjee, R. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31827ee1c2 · Cited by 58
Adverse effects of parenteral antimicrobial therapy for chronic bone infections
Pulcini, C., Couadau, T., Bernard, E., Lortat-Jacob, A., Bauer, T. W., Cua, É., Mondain, V., Chichmanian, R. M., Dellamonica, P., & Roger, P. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0570-y · Cited by 57
Beieler, A. M., Dellit, T. H., Chan, J. D., Dhanireddy, S., Enzian, L., Stone, T. J., Dwyer-O’Connor, E., & Lynch, J. B. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2597 · Cited by 57
Dryden, M., Andrašević, A. T., Bassetti, M., Bouza, E., Chastre, J. E., Cornaglia, G., Esposito, S., French, G. L., Giamarellou, H., Gyssens, I. C., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03135.x · Cited by 57
Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
Martone, W. J., Lindfield, K. C., & Katz, D. E. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01824.x · Cited by 55
Muldoon, E. G., Switkowski, K. M., Tice, A. D., Snydman, D. R., & Allison, G. M. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.967290 · Cited by 55
Self-citationNathwani, D., Eckmann, C., Lawson, W., Stephens, J., Macahilig, C. P., Solem, C. T., Simoneau, D., Chambers, R. B., Li, J. Z., & Haider, S. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12632 · Cited by 55
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.